. TET proteins have roles in diverse biological processes, including epigenetic regulation of gene transcription, embryonic development, stem cell function and cancer, but the mechanism s underlying these roles are still poorly defined.
Here, we review our current understanding of TET enzymes and their biological functions, focusing on recent studies not covered in previous reviews [10] [11] [12] [13] [14] . We discuss the established and controversial roles of TET proteins and methylcytosine oxidation products in DNA demethylatio n, gene regulation and embryonic development. The role of TET proteins in haematopoietic differentiation and oncogenesis has been reviewed elsewhere 10, [15] [16] [17] ; their role in neurons is only briefly discussed here owing to space limitations.
TET proteins are 5mC oxidases
The prediction that TET proteins might have DNAmodifying activity was based on the analysis of J-binding protein 1 (JBP1) and JBP2 from Trypanosoma brucei, the causative parasite of African sleeping sickness in humans 18 . Leishmania species, trypanosomes such as T. brucei and other kinetoplastids contain a modified thymine known as 'base J' (β-d-glucosyl-hydroxymethyluracil) 19 . JBP1 and JBP2 generate base J by oxidizing the methyl group of thymine to yield 5-hydroxymethyluracil, and the resulting hydroxyl group is then glucosylated by an unknown glucosyltransferase 20 (FIG. 1b) . JBP enzymes are members of a large family of Fe 2+ -and 2-oxoglutarate-dependent dioxygenases 21, 22 ; AlkB enzymes, which remove aberrant methylation from damaged DNA bases by an oxidative mechanism, are distantly related members of the same superfamily [21] [22] [23] . In T. brucei, base J is present at subtelomeric repeats, at inactive copies of the variant surface glycoprotein that is used by the parasite to evade host immune defence and at other silenced regions of the genome 24 . In Leishmania species, base J was recently shown to restrain elongation of the unique polycistronic transcripts of kineto plastids beyond transcription stop sites 25 . Computational screens to identify additional homologues of JBP enzymes revealed a large family of predicted nucleic acid-modifying dioxygenases from diverse eukaryotes and bacteriophages, which included the metazoan TET enzymes 2, 18 . A gene encoding an enzyme of the TET-JBP family entered the common ancestor of the metazoan lineage and fused with a second gene containing a CXXC domain (described below), forming the TET subfamily 2 . TET enzymes are present in all metazoans that have retained cytosine methylation but are absent in organisms such as Caenorhabditis elegans in which methylation has been unambiguously lost 2 . The coexistence of TET proteins with DNA methylation, their association with CXXC domains which frequently bind unmethylated CpG sequences (see below) and the Nature Reviews | Molecular Cell Biology Figure 1 | Mechanisms of TET-mediated demethylation. a | Known and putative pathways of DNA demethylation that involve oxidized methylcytosine intermediates. Ten-eleven translocation (TET) proteins sequentially oxidize 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). 5fC and 5caC can be removed by thymine DNA glycosylase (TDG) and replaced by cytosine via base excision repair (BER), although the extent to which this mechanism operates in specific cell types during development is unknown. Other proposed mechanisms of demethylation are less well established, including decarboxylation of 5caC, DNA methyltransferase (DNMT)-mediated removal of the hydroxymethyl group of 5hmC and deamination of 5hmC (and 5mC) (see main text) by the cytidine deaminases AID (activation-induced cytidine deaminase) and APOBEC (apolipoprotein B mRNA editing enzyme, catalytic polypeptide). AID enzymes deaminate cytosine bases in DNA to yield uracil. AID and the larger family of APOBEC enzymes have been proposed to effect DNA demethylation by deaminating 5mC and 5hmC in DNA to yield thymine and 5hmU, respectively. As these are present in mismatched T:G and 5hmU:G basepairs, they have been proposed to be excised by SMUG1 (single-strand-selective monofunctional uracil DNA glycosylase) or TDG. This mechanism is controversial, however (see main text). b | The mechanism of base J (β-d-glucosyl-hydroxymethyluracil) biosynthesis. The thymidine oxidation step mediated by J-binding protein 1 (JBP1) or JBP2, to produce 5-hydroxyuracil (5hmU), is analogous to the 5mC oxidation mediated by TET proteins. JBPs are the founding members of the TET-JBP superfamily: the predicted oxygenase domains of JBP1 and JBP2 were used as the starting point for the sequence profile searches that recovered the homologous domains of the three mammalian TET proteins. c | Mechanism by which 5hmC could facilitate replication-dependent DNA demethylation. A symmetricallymethylate d CpG sequence is converted during DNA replication into two asymmetrically methylated DNA strands (left panel). Hemimethylated CpG sites are recognized by UHRFI, the obligate partner of the maintenance DNA methyltransferase DNMT1, which restores symmetrical methylation. TET proteins act at methylated CpG sites to generate symmetrically hydroxymethylated CpG sequences. 5hmC and other oxizided methylcytosines may impair maintenance methylation by inhibiting UHRF1 binding, DNMT1 activity, or both (right panel). As a result, the CpG sequence progressively loses DNA methylation through successive DNA replication cycles.
CXXC domain
A Zn 2+ -chelating domain typified by the signature amino acid sequence CGXCXXC(X) N C, in which X represents any amino acid. CXXC domains in metazoans always contain two such sequences.
CpG sequences
Any instance of a cytosine followed immediately by a guanine on the same strand of DNA. Most DNA methylation in mammals occurs at CpG sites.
chemical similarity of thymine and 5mC oxidation all led to the proposal that TET proteins might function as 5mC oxidase s and potentially as DNA demethylases 2, 18 . Indeed, ectopic expression of TET proteins in cell lines reduces 5mC levels and causes the appearance of 5hmC, and this activity is abrogated by mutation of the signature His-Xaa-Asp motif (where Xaa represents any amino acid) of these dioxygenases 1,26,27 (see below). Recombinant TET catalytic domains and full-length TET proteins efficiently convert 5mC to 5hmC in vitro in the presence of the essential cofactors 2-oxoglutarat e and Fe 2+ (REFS 1,27). TET proteins also produce the further oxidation products 5fC and 5caC 5,6,28 (FIG. 1a) . Thus, the successive actions of DNA methyltransferases (DNMTs) and TET proteins produce four distinct cytosine modifications, bringing the total number of cytosine species to five (FIG. 1a) .
5hmC is found at different levels in mammalian cells: it is present at 1% of the total level of 5mC in some immune cell populations 26 , ~5-10% of the level of 5mC in embryonic stem (ES) cells 1 and as high as 40% of 5mC in Purkinje neurons 9 . Consistently, the highest reported levels of 5hmC are in the brain 5, 7, 8 . An early report of 5hmC in mammalian DNA 29 is questionable, as in this study 5mC was not detected in mouse brain and liver DNA, whereas the level of 5hmC was unrealistically high (15-17% of all cytosines), suggesting massive oxidation of 5mC during the unconventional DNA extra ction procedure devised by this group 29 . 5fC and 5caC are present in mammalian cells at much lower levels than 5hmC (0.03% and 0.01%, respectively, of the level of 5mC in mouse ES cells) 5, 6, 28 , at least partly because there are enzymatic mechanisms for their removal. These include base excision by thymine DNA glycosylase (TDG) 6,30 and possibly decarboxylation of 5caC by unknown enzymes present in ES cell lysates 31 (FIG. 1a) .
Domain structure of metazoan TETs
Most metazoan TET proteins contain an amino-t erminal CXXC domain (~60 amino acids) and a carboxy-termina l catalytic domain (FIG. 2a) , the core of which adopts a doubl e-stranded β-helix (DSBH) fold 1, 2 . Metazoan TET proteins can be distinguished from all other members of the TET-JBP family by a Cys-rich domain in the N-terminal region of the DSBH domain. In jawed vertebrates, the TET gene underwent triplication, giving rise to TET1, TET2 and TET3. TET2 then underwent a chromosomal inversion event in which the exon containing the CXXC domain was detached and became a separate gene that encodes IDAX (inhibition of the Dvl and axin comple x; also known as CXXC4) 2,32 (FIG. 2a, b) .
CXXC domains occur in many chromatin-associated proteins. Three distinct subfamilies of CXXC domains can be identified by their sequence 33 (Supplementary information S1 (figure)). Subfamily 1 includes the CXXC domains of CXXC1 (also known as CFP1), DNMT1, MLL and Lys-specific demethylase (KDMA) family proteins, as well as the third CXXC domain of methyl CpG-binding protein 1 (MBD1); these CXXC domains specifically recognize unmodified CG sequences and target subfamily 1 proteins to CpG-rich sequences in DNA [34] [35] [36] [37] [38] . Subfamily 3 includes the CXXC domains of TET1, TET3,  IDAX and RINF (retinoid-inducible nuclear factor; also  known as CXXC5) 2, 39 . The IDAX CXXC domain preferentially binds unmethylated CpG sequences in vitro, and is found at CpG islands and CpG-rich promoters (which are predominantly unmethylated) in cells (Ref. 41) . Curiously, however, the TET1 CXXC domain is reported not to bind DNA 33 or alternatively to bind CpG sequences regardless of whether the cytosine is modified 39, 40 , and the TET3 CXXC domain is reported to bind unmodified cytosine irrespective of whether it is followed by a guanine, a finding supported by affinity measurements and X-ray crystallography 42 . As subfamily 3 CXXC domains have a strong positive charge that increases their tendency to bind nonspecifically to DNA, an analysis of binding sites in vivo is needed to reconcile these in vitro findings.
Surprisingly, IDAX (a reported inhibitor of WNT signalling 43 ) targets TET2, the protein from which it was separated during evolution, for destruction via a caspase-dependent mechanism 41 . Depletion of IDAX from ES cells prevented the downregulation of TET2 that normally occurs upon differentiation, whereas its depletion from a human myeloid cell line increased TET2 and 5hmC levels. IDAX cannot negatively regulate TET2 if key DNA-binding residues in the IDAX CXXC domain are mutated, suggesting that IDAX recruits TET2 to DNA before the caspase-dependent degradation mechanism is activated. The implication is that TET2, which like other TET proteins is likely to also bind DNA through the cysteine-rich region of its catalytic domain (see below), binds different sets of genomic regions depending on whether IDAX is present. The CXXC domain of TET3 negatively regulates TET3 catalytic activity perhaps through an autoinhibitory mechanism that involves a physical interaction between the CXXC and catalytic domains or, alternatively, by tethering TET3 to particular DNA elements and thus limiting its genome-wide activity.
The catalytic domains of TET proteins are characteristic of Fe 2+ -and 2-oxoglutarate-dependent dioxygenases (reviewed in REF. 22 ). The DSBH fold, which comprises the catalytic domain of all these dioxygenases, contains an His-Xaa-Asp/Glu signature motif, a C-terminal conserved His residue that is involved in coordinating Fe 2+ and a conserved Arg residue that binds 2-oxoglutarate via a salt bridge 21, 22 . Because a crystal structure of the TET catalytic domain is not yet available, the structure of the AlkB DSBH domain and a detailed view of the active site 44 are shown in FIG. 2c . As is the case for AlkB, the substrate 5mC is likely to be flipped out of the DNA double helix into the catalytic cavity of the TET protein, where it is brought in close proximity to the catalytic Fe 2+ ion (FIG. 2c) .
The inserted Cys-rich domain in the catalytic region of TET proteins is likely to chelate two or more Zn 2+ ions via nine conserved Cys residues and one His residue, and has been postulated to be part of a DNA-binding surface that might help in target recognition 2 . Indeed, the same region contains comparable insertions in the distantly related Jumonji-like family 45 (for example, the AT-rich interaction domain (ARID; also known as BRIGHT) in Jumonji and ARID domain-containing 1 (JARID1) and the histone-binding PHD finger in SMCX (also known as KDM5C or JARID1C)). Metazoan TET proteins also contain a large low-complexity insert predicted to be on the exterior surface of the DSBH fold 2,32 (FIG. 2c) . A chromosomal inversion then detached the catalytic domain of TET2 from its CXXC domain, which became a separate gene (which encodes IDAX (inhibition of the Dvl and axin complex)). c | A cartoon representation of AlkB (Protein Databank (PDB) identifier: 2FD8), a protein that belongs to the same superfamily as the TET proteins and shares a common fold with them. AlkB is shown as a complex with its substrate methyladenine and its cofactor 2-oxoglutarate (2OG). In the 2OG structure, carbon atoms are shown pink, in the rest of the structure carbons are shown in grey. Nitrogens are shown in blue, oxygens in red and phosphates in orange (left panel). A stripped-down view of the active site of AlkB in complex with its substrate methlyadenine. Note the series of interactions, including pi-pi stacking interactions, between the His residues and the target base, and cation-pi interaction with the active site metal. Such interactions are likely to be retained in the TET-J-binding protein (JBP) family. In the 2OG structure, carbon atoms are shown in cyan and oxygens in red. In the protein structure, carbons are shown in grey, nitrogens in blue and oxygens in red. In methyladenine, carbons are orange and nitrogens are blue. Dashed yellow lines represent hydrogen bonds (right panel). The sequence and size of this unstructured insert varies greatly between TET family members, but its continued presence indicates a function, perhaps as a site of protei n-protein interaction 2, 32 .
TET-mediated DNA demethylation: mechanisms Interest in TET proteins has primarily centred around the possibility that oxidized methylcytosines could serve as intermediates in one or more 'DNA demethylation' pathways. In such a pathway, TET would oxidize 5mC to 5hmC, 5fC or 5caC, which would then be replaced with cytosine, the net result thus being 'demethylation' . There are at least four mechanisms by which TET protein s could mediate DNA demethylation (FIG. 1a) .
Facilitation of passive DNA demethylation. Because CG sites are palindromes that in general are symmetrically methylated 46 , DNA replication yields two strands with hemimethylated CG sites. Maintenance of DNA methylation patterns requires the DNA methyltransferase DNMT1 and its obligate partner UHRF1 (REF. 47 ) (FIG. 1c) . UHRF1 binds to hemimethylated CpG sites via its SAD/ SRA (SET associated Deinococcus domain (SAD)/SET and RING associated (SRA) domain) domain and recruits DNMT1. DNMT1 then methylates the CG sites on the nascent DNA strand, thus maintaining methylation patterns through cell division 47, 48 . In vitro, UHRF1-hemi-5hmC binding is tenfold less efficient than UHRF1-hemi-5mC binding 49 . In addition, the activity of recombinant DNMT1 is reduced 12-fold 50 or 50-fold 49 at sites of hemi-5hmC in vitro. Together, these results imply that the TET-mediated hydroxymethylation of a methylated CG site in vivo can block maintenance methylation during cell division and eliminate 5mC in a 'passive' , replication-dependent manner. However, hydroxymethylated plasmids stably transfected into transformed human cells retain maintenance methylation through cycles of plasmid division as efficiently as a methylated plasmid 51 , suggesting that 5hmC does not completely block maintenance methylation in cells.
Active DNA demethylation through DNA repair. Two replication-independent ('active') demethylation mechanisms have been reported to couple the methyl cytosine oxidase activity of TET proteins with base excision repair (BER). The first, which involves 5fC, 5caC and TDG, has been confirmed by multiple laboratories 6, 30, 53 . The second mechanism, which involves AID (activationinduced cytidine deaminase) and APOBEC (apolipoprotein B mRNA editing enzyme, catalytic polypeptide), is still controversial 52, 54 . In the first mechanism, TET proteins further oxidize 5hmC to generate 5fC and 5caC 5, 6, 28 . 5fC and 5caC can be excised by TDG 6,30 ; their replacement with cytosine results in demethylation (FIG. 1a) . Electrophoretic mobility shift assays (EMSAs) and the structure of TDG in complex with 5caC 53 indicate that TDG binds 5caC:G mismatches with higher affinity than T:G mismatches (its conventional substrate). Depletion of TDG causes a 2-10-fold increase in the levels of 5fC and 5caC in ES cells 6, 55, 56 , consistent with a model in which these bases are short-lived demethylation intermediates that are removed by TDG. However, even in a TDG-deficient cell, 5fC is rare compared with 5mC (0.2-0.3% of the total methylcytosines) 5, 55, 56 , and 5caC is even less abundant 6,56,, indicating that this demethylation pathway has limited throughput in ES cells.
The second DNA repair-based mechanism has been reported by one laboratory in transfected human cells and in mouse brain 52 . They proposed that 5hmC is deaminated to 5-hydroxyuracil (5hmU) by AID and APOBEC family enzymes, removed by SMUG1 (singlestrand-selective monofunctional uracil DNA glycosylase 1) or TDG glycosylases and ultimately replaced by cytosine (FIG. 1a) . This sequential deamination and removal of 5hmC is similar to the deamination of 5mC and the removal of the resulting T:G mismatches by TDG, a mechanism previously proposed to occur in zebrafish 57, 58 , human cancers 58 , primordial germ cells 59 and fused cells undergoing reprogramming 60 . However, there is considerable controversy about the significance of deamination-based demethylation mechanisms in general. In support of such mechanisms, TDG can excise T:G mismatches and 5hmU:G mismatches in vitro 54, 61 , and both PGCs derived from Aid-deficient mice and mouse embryonic fibroblasts (MEFs) derived from Tdg-deficient mice have modestly increased levels of methylation at some CpG island promoters 61, 62 . Arguing against a deamination mechanism, the AID enzyme primarily acts on single-stranded DNA 63 , and recombinant AID and APOBEC enzymes have their strongest activity against unmodified cytosine with reduced activity against 5mC and no detectable activity against 5hmC 54, 64 . It therefore seems unlikely that AID and APOBEC enzymes have a role in 5hmC-dependent demethylation pathways, although their involvement in specific situations cannot be ruled out.
Enzymatic decarboxylation of 5caC. There is some evidence that 5caC may be decarboxylated by protein(s) present in ES cell lysates. An oligonucleotide containing 5caC that was labelled with 15 N at both positions of the pyrimidine ring was synthesized and incubated with ES cell lysate. Following the recovery and digestion of the oligonucleotide, a small but detectable quantity of The factors that catalyse this decarboxylation reaction remain to be identified.
Dehydroxymethylation by DNMT enzymes. Remarkably, DNMT enzymes can remove the hydroxymethyl group of 5hmC in vitro, directly converting 5hmC to cytosine 65, 66 (FIG. 1a) . Reducing conditions favour the methyltransferase activity of DNMT3A, whereas oxidizing conditions favour dehydroxymethylation 66 . Whether this reaction occurs in cells is still unknown. Two papers reported cyclical changes in the DNA methylation status of several oestrogen-responsive genes upon the addition of oestrogen 67, 68 , and one of these also showed cyclical recruitment of all three DNMTs 67 . It would be interesting to revisit this system to determine whether reciprocal actions of TET proteins and DNMTs were involved.
Click chemistry
Chemistry involving high-yield, highly specific reactions that are compatible with physiological conditions and maintain the integrity of biological molecules.
When a biological role is observed for a TET protein, there has been a strong tendency in the literature to invoke DNA demethylation as a major mechanism. However, an unequivocal demonstration of demethylation can be difficult, especially as the changes observed in most studies have been subtle. At a given locus, TET may simply be converting 5mC to 5hmC, or it may be converting 5mC to cytosine via an oxidized 5mC intermediate by one of the pathways described in FIG. 1a. Actual DNA demethylation only occurs when 5mC is converted to cytosine via an oxidized 5mC inter mediate. TET depletion will necessarily result in decreased 5hmC, 5fC and 5caC, and a corresponding increase in 5mC from which these oxidized methylcytosines are derived. Thus, a simple increase in 5mC upon TET depletion is not enough to prove that a TET protein is causing demethylation. Rather, the increase in 5mC has to be greater than the attendant decrease in 5hmC, 5fC and 5caC. If TET is demethylating a locus, TET depletion will result in a decrease in unmodified cytosine as judged by bisulphite sequencing. Even here, caveats apply: 5fC and 5caC will appear as unmodified cytosine. Another point to bear in mind is that binding of transcription factors to a TET-regulated locus may antagonize DNA methylation , thus if TET depletion results in altered transcription factor binding, the resulting changes in cytosine species could lead to incorrect interpretations of whether TET is causing demethylation at that locus or not. Methylated DNA immunoprecipitation (MeDIP) and other methods of measuring 5mC abundance are less useful than bisulphite sequencing, as simple conversion of 5mC to 5hmC will produce a drop in measured methylation even if TET does not mediate demethylation at the locus.
Genomic distribution of oxidized 5mC
Large-scale mapping of 5hmC, and more recently 5fC and 5caC, has been performed for mammalian genomes. The available methods for mapping these modified bases are outlined in BOX 1 and BOX 2. Commercial kits are available in many cases.
Oxidized methylcytosine enrichment at promoters.
There is contention as to whether 5hmC is enriched at promoters, owing largely to how 'promoter' and ' enrichment' are defined. First, the definition of promoter varies between laboratories. Many promoters that are CpG-rich contain peaks of hydroxymethylation 500-2000 bases before and after the transcription start site (TSS) but are depleted for 5hmC at the TSS itself, where there is typically almost no modified cytosine 73, 74 . In this Review, we classify these promoters as 5hmC-enriched. Second, the definition of enrichment varies depending on whether precipitation-based or single-base resolution methods are used. Precipitation-based metho dologies compare how many times a given region of DNA is sequenced in a 5hmC pulldown compared with a negative control sample. As a result, regions that contain a higher than average number of 5hmC residues in a span of several hundred bases will be classified as enriched. In contrast, single-base resolution studies typically measure the fraction of total reads in which an individual CpG site is hydroxymethylated. Thus, promoters with a high CpG density, but in which each CpG site has a relatively low frequency of 5hmC, may be classified as 5hmC-enriched by a p recipitation-based methodology but as 5hmC-depleted by a single-base methodology. We will predominantly discuss results from precipitation-based studies, although it is unclear which definition of enrichment is more bio logically relevant. Furthermore, any given cytosine modification is either present or absent at any given CpG site at the level of a single allele, but can seem infrequent when a large, potentially h etero-genous population of cells is examined.
In human 73, 75 and mouse 11,74,76 ES cells, mouse neural progenitor cells 77 , mouse neurons 77 and the cerebellum of 7-day-old mice 78 (which contains a significant population of neural progenitor cells), 5hmC is enriched at promoters in absolute terms and especially when compared with 5mC, which is generally depleted at promoter s 79 . In these cell types, genes with hydroxymethylated promoters are expressed at lower levels than other genes, Box 1 | Detecting and mapping modified cytosines by DNA precipitation 5hmC immunoprecipitation This is the most straightforward method for detecting 5-hydroxymethylcytosine (5hmC) and has been used by many laboratories 39, 84, 93, 126, 141 . However, the efficiency of precipitation strongly depends on the density of 5hmC in the samples 26, 76 ; there are notable variations in the results obtained in different laboratories 39, 84, 93, 126 , and there is evidence that the 5hmC-specific antibody precipitates poly-CA repeats, resulting in spurious peaks immediately adjacent to such repeats 142 .
CMS immunoprecipitation
When 5hmC is treated with sodium bisulphite, it is converted into a compound called cytosine methylene sulphonate (CMS) 143 . CMS is highly immunogenic, and CMS immuno precipitation recovers 5hmC-containing DNA with high specificity and low background 76, 144 .
GLIB (glucosylation, periodate oxidation, biotinylation)
Glucose is attached to the hydroxyl group of 5hmC using the enzyme β-glucosyl transferase (BGT) from phage T4. Glucose is then oxidized with sodium periodate and treated with aldehyde reactive probe (ARP) to generate an adduct containing two biotins at the site of every 5hmC 76, 145 . The hydroxymethylated DNA is then precipitated with streptavidin beads.
JBP1
5hmC is glucosylated by BGT. The glucosylated base is bound by J-binding protein 1 (JBP1), which is conjugated to a bead, allowing for selective precipitation of hydroxymethylated DNA 146 . The precipitation of 5hmC is highly specific, but not very efficient. This method has not yet been used for the genome-wide mapping of 5hmC.
5-hmC selective chemical labelling (hMe-Seal)
BGT adds a glucose-azide conjugate to 5hmC, which can then be biotinylated under gentle conditions using click chemistry 73, 147 .
5fC-DNA pulldown
An ARP molecule biotinylates the formyl group of 5fC 83 . This method was used to generate the first published genome-wide map of 5fC 83 , but it also biotinylates abasic sites to some extent 55 .
5fC-Seal
BGT is used to protect 5hmC by linking it to an unmodified glucose. 5fC is then reduced to 5hmC using sodium borohydride (NaBH 4 ), and the product then reacts with gluc ose-azide and is biotinylated as in hMe-Seal. Thus, 5fC is selectively biotinylated 55 . 5fC and 5caC immunoprecipitation Antibodies specific for 5fC and 5caC have been used to precipitate these modifications for sequencing, although the efficiency of precipitation is fairly low 56 .
Sequencing coverage
Average number of times that a genome or a DNA region is sequenced using a next-generation sequencing instrument.
although this does not prove a silencing role for 5hmC; 5hmC can only be formed at promoters that have some underlying level of methylation, and promoter methylation correlates with silencing. In other cell types, including PGCs 80 , adult nervous tissue 78 , liver cells 81 and benign nevi 82 , 5hmC is depleted from TSSs. The discrepancies in 5hmC distribution among cell types could be caused by differences in the underlying distribution of 5mC and TET proteins.
In ES cells, 5fC is found at largely the same set of promoters as 5hmC 83 , and levels of 5fC 55 and 5caC 56 increase at these promoters upon TDG depletion, indicating that at least some TET-mediated demethylation occurs at these loci.
Oxidized methylcytosine enrichment at gene bodies.
In virtually all mammalian cell types studied, including mouse and human ES cells, mouse liver and brain and human melanomas, 5hmC is enriched at gene bodie s 11, 73, 77, 78, 81, 82 . In mouse brain, liver and ES cells (but not in human ES cells), gene expression positively correlates with gene body hydroxymethylation 78, 84, 85 , [86] [87] [88] , making it unclear how 5mC oxidation and/or DNA demethylation by TET proteins in gene bodies affects gene expression.
Oxidized methylcytosine enrichment at enhancers. In all mammalian cells in which both 5hmC and enhancers have been mapped, 5hmC is strongly enriched at enhancers 72, 73, 75, 81, 89 , which are often regions of low CpG density with reduced levels of DNA methylation compared with neighbouring regions 72 . Single-base resolution mapping using TET-assisted bisulphite sequencing (TAB-seq) (BOX 2) indicates that 5hmC is strongly enriched immediately adjacent to transcription factor-binding sites in enhancers, but is depleted at the precise site of binding 89 . Due to the absence of data on the binding of transcription factors to enhancers in TET-deficient cells, it is difficult to know whether methylcytosine oxidation 'opens' chromatin structure, allowing transcription factors to bind, whether transcription factors recruit TET proteins or whether both mechanisms operate and reinforce one another. Moreover, the reduction in 5mC and 5hmC at transcription factor-binding sites may reflect demethylation mediated by TET proteins, but could also be because transcription factors physically block access of DNMT 69, 90 and TET proteins. Probably, both mechanisms are at work.
Notably, in differentiating ES cells, 5hmC levels increase sharply at activated enhancers 91 . 5hmC levels rise almost immediately with the onset of differentiation and either precede or accompany acetylation of Lys27 of histon e H3 (H3K27), which is a mark of active enhancer s. Furthermore, 5fC and 5caC are enriched at enhancers in TDG-depleted ES cells, consistent with TET-mediated demethylation of enhancers 55, 56 . However, the correlation between the 5fC levels at enhancers and hypomethylation is weak 55 . Further studies will be necessary to determine the extent to which TET proteins contribute to enhancer hypomethylation and function.
Mapping TETs and TET-interacting proteins
The distributions of TET proteins and oxidized 5mC species do not overlap neatly. All three TET proteins and IDAX are strongly enriched at promoters, especially promoters that are CpG-rich 39 
Box 2 | Mapping 5hmC at base pair resolution
The simplest and most widespread method for distinguishing cytosine from 5-methylcytosine (5mC) -treatment with sodium bisulphite followed by PCR amplification and bisulphite sequencing (BS-seq) [148] [149] [150] -conflates the five cytosine species into two groups. 5mC and 5-hydroxymethylcytosine (5hmC) are resistant to deamination by sodium bisulphite and thus are read as cytosine, whereas cytosine, 5-carboxylcytosine (5caC) and 5-formylcytosine (5fC) are deaminated and so are read as thymine 6, 89, 151 (see the table) . Methods have been developed that distinguish 5hmC or 5fC from each other and from other cytosine species at base resolution, although there is no method yet that allows all five bases to be distinguished simultaneously.
Single molecule real time (SMRT) sequencing
Using chemistry similar to 5hmC selective chemical labelling (hMe-Seal)
, a bulky conjugate is added to sites of 5hmC. The conjugate stalls a specially designed polymerase during DNA replication, and this stalling is monitored in real time to identify 5hmC 152 . This method, as well as the oxidative bisulphite sequencing (Ox-BS-seq) and TET-assisted bisulphite sequencing (TAB-seq) methods (see below), provide single-base resolution mapping of 5hmC. 5fC and 5caC produce substantial delays in replication even without the addition of a conjugate, although it is hard to distinguish them from each other 153 . SMRT sequencing can handle long DNA fragments (6-10 kb) but does not yet exhibit the throughput required for genome-wide mapping in mammalian cells.
OxBS-seq
5hmC is oxidized to 5fC using potassium perruthenate 151 . Bisulphite sequencing is performed on the same sample both before and after oxidation. As 5hmC is unaffected by sodium bisulphite treatment and 5fC is deaminated, the extent of 5hmC at a site can be approximated by subtracting the frequency of deamination after perruthenate oxidation from the frequency of deamination before oxidation. 5hmC is a rare base, so very high sequencing coverage is required to determine the extent of hydroxymethylation.
TAB-seq 5hmC is protected from oxidation by β-glucosyl transferase (BGT)-mediated glucosylation, and then all 5mC bases are oxidized to 5caC using a recombinant ten-eleven translocation (TET) enzyme 89 . After bisulphite treatment, all cytosine species are therefore deaminated, except those that were originally 5hmC, so these can be read specifically. TAB-seq has revealed that 5hmC is often asymmetric with cytosine or 5mC at CpG sites. Like Ox-BS, this method requires very high sequencing coverage. 5fC chemically assisted bisulphite sequencing (fCAB-seq) 5fC is normally deaminated by sodium bisulphite treatment, but when it reacts with O-ethylhydroxylamine, deamination is prevented. The extent of 5fC at a site can be approximated by subtracting the frequency of deamination after the bisulphite treatment of unreacted samples from the frequency of deamination after the bisulphite treatment of O-ethylhydroxylamine-treated sample. Although the technique is selective, 5fC is very rare, so extremely high sequencing coverage (>1000 fold) must be used to accurately map the base.
Base
Read by BS-seq
Read by oxBS-seq

Read by TAB-seq
Read by fCAB-seq
Cell formed by fertilization of the oocyte (egg) with a sperm cell.
Imprinted locus
In epigenetics this describes a genomic region with a methylation mark that is present only on the maternally or paternally derived copy of an allele.
and TET3 (REF. 42 ), this preference is partially determined by the presence of CXXC domains, which most likely bind CpG sequences, as discussed above. The data support a repressive role for TET1 in ES cells. In three studies in mouse ES cells, there is a strong statistical correlation between the physical presence of TET1 at a promoter and increased gene expression from this promoter upon TET1 knockdown 39, 92, 93 . The correlation between the presence of TET1 at a promoter and decreased expression from this promoter upon TET1 knockdown is much weaker. TET2 shows precisely the opposite trend: there is a correlation between the physical presence of TET2 at a promoter and decreased expression from this promoter upon TET2 depletion, which indicates that TET2 is generally a positive regulator of gene expression 95 . The likely explanation for the different activities of TET1 and TET2 is that, in ES cells, TET1 primarily modulates transcription by recruiting the repressive histone deacetylase-containing MBD3-NURD (nucleosome remodelling and deacetylase) 96 and SIN3A (switchindependent 3A) complexes 13, 94, 97 to promoters. TET2 shows no association with these complexes in ES cells 93 and, when exogenously expressed in 293T cells, TET1 and TET3 associate with SIN3A, whereas TET2 does not 94 . Furthermore, in contrast to somatic cells in which methylation has an impact on the expression of thousands of genes 98 , methylation only regulates a handful of genes in ES cells and is dispensable for ES cell growth and survival 99 . Hence, the demethylating properties ascribed to TET proteins may be of limited importance in regulating transcription in ES cells.
Recently, three groups have reported a physical association between TET proteins and the enzyme OGT (O-linked β-d-N-acetylglucosamine (O-GlcNAc) transferase) 94, 95, 97 . Despite some contradictions in these studies, it is probable that all three TET proteins associate with OGT 100 . OGT adds a GlcNAc sugar to Ser and Thr residues of numerous proteins, including histone H2B and other chromatin modifiers. The impact of this sugar modification on the target protein is highly contextual. For instance, O-GlcNAcylation can serve to antagonize phosphorylation, direct proteolysis or allow proteinprotei n interaction 101 . OGT, like TET proteins, is strongly enriched at promoters. In ES cells, TET proteins recruit OGT to promoters, but not vice versa. Depletion of TET proteins diminishes the amount of OGT at promoters, but depletion of OGT does not influence the association of TET1 or TET2 with chromatin, although it does alter the distribution of 5hmC at certain loci 95, 97 . There are various mechanisms by which OGT could influence transcription. For example, levels of O-GlcNAcylation at Ser112 of H2B, a mark associated with transcriptional activation 102 , drop sharply upon TET2 depletion providing a mechanism whereby TET2 increases transcription through OGT. Likewise, OGT glycosylates HCF1 (host cell factor 1), a component of the H3K4 methyltransferase SET1 complex (also known as COMPASS) associated with active RNA polymerase II (Pol II), providing a link between H3K4 trimethylation and TET proteins 94 . Given the many protein targets of OGT, it is likely that there will be additional consequences of TET-mediated OGT recruitment.
TET proteins in embryonic development TET proteins are implicated in several stages of mouse development, particularly those in which mass demethylation and de novo methylation take place, namely the zygote, the inner cell mass of the blastula and PGCs (FIG. 3) . The phenotypes of TET-deficient mice are described in BOX 3.
TET3 in the zygote. Immediately after fertilization, before the genetic material from the sperm and egg have fused to form one nucleus, the male pronucleus loses almost all methylation as assessed by staining with antibodies specific for 5mC [103] [104] [105] (FIG. 3) . This process occurs before replication and is not inhibited by DNA polymerase inhibitors. In contrast, bisulphite sequencing, which does not distinguish between 5mC and 5hmC [106] [107] [108] (BOX 2), indicates that this loss of 5mC is much slower and less complete than the abrupt loss measured by antibody staining 104, [109] [110] [111] . These results are reconciled by the observation that the zygotic demethylation event is in fact a mass 5mC oxidation event; the apparent loss of 5mC stems from the fact that 5mC-specific antibodies do not recognize 5hmC or other oxidized methylcytosines. Instead, the male pronucleus shows a selective increase in 5hmC [111] [112] [113] and other oxidized methylcytosines 114 , as observed by staining with appropriate antibodies. The increase in 5hmC is abrogated by siRNA-mediated knockdown of Tet3 (REF. 112 ), and is not observed in fertilizations that involve TET3-deficient oocytes 113 . This indicates that TET3 oxidizes 5mC in the male pronucleus.
The protein DPPA3 (development pluripotencyassociated 3; also known as Stella or PGC7) protects maternal DNA and a few imprinted loci in the paternal genome from TET3-mediated oxidation 115 . DPPA3 is reported to be recruited to the protected regions by dimethylation of H3 at Lys9 (H3K9me2), a mark that is found selectively at these sites 115 . In the absence of DPPA3, both paternal and maternal genomes become hydroxymethylated 112, 115 and most show abnormal ities by the 2-cell or 4-cell stage [116] [117] [118] . In contrast, Tet3-deficient oocytes fertilized with wild-type sperm have reduced expression of OCT4 during the morula stage but form blastocysts normally. Moreover, about half of these animals show serious abnormalities by embryonic day E11.5 and fail to develop 113 . Thus, methylcytosine oxidation in the male pronucleus enhances, but is not required for, survival of the embryo. It is not clear why some zygotes survive, whereas others do not, and why it takes 11 days for the failure of zygotic oxidation to result in lethality.
The bulk of the evidence suggests that cytosine modification is lost through a replication-dependent process that may be enhanced by, but is not completely dependent on, TET enzymes or BER. In fact, maintenance methylation is very inefficient in the early embryo because of the cytoplasmic localization of DNM1O, which is a special splice variant of DNMT1 present in the early mouse embryo 80, 103, 105 . As a result, 5mC on the maternal DNA and 5hmC on the paternal DNA are diluted out through a passive replication-dependent process (FIG. 3) . 
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Embryoid bodies
Aggregates of cells formed by allowing embryonic stem cells to differentiate without contact with a solid surface.
Substantial levels of 5hmC are retained at least through the 8-cell stage 111, 119 , arguing against the possibility that it is excised or converted directly to cytosine. However, some loss of 5mC is observed by bi sulphite sequencing before any cell replication event 113 . A likely explanation for this is that TET3 is oxidizing 5mC to 5fC and 5caC 114 , creating the appearance of demethylation by bisulphite sequencing (BOX 2) . It is also plausible that some proportion of 5fC and 5caC is removed by TDG and replaced by cytosine 30 . Evidence showing BER in the male pronucleus supports this possibility 110, 120 . Arguing against direct removal of 5fC and 5caC is evidence demonstrating that the modified bases remain in the embryo at least until the 4-cell stage 114 and the fact that large-scale BER would be expected to cause increased rates of mutations in the zygote, which would be deleterious to the organism and its progeny.
As methylation is lost passively anyway, why are methylcytosines oxidized in the mammalian zygote? The most likely possibility is that methylcytosine oxidation in the male pronucleus accelerates global DNA demethylation, either through 5fC and 5caC formation and the subsequent removal of these modified bases or by ensuring that maintenance methylation is especially inefficient in the earliest cell divisions. No proof of either mechanism has been demonstrated. It is also possible that cytosine oxidation promotes broad transcriptional activation previously observed in the male pronucleus 121 . However, depletion of TET3 in the early zygote is reported to have no effect on global transcriptional levels 122 . In short, it is clear that TET3 oxidizes the male pronucleus and that this oxidation event enhances survival of the early embryo, but why this oxidation occurs remains unknown. [111] [112] [113] , mediated by ten-eleven translocation 3 (TET3). 5-methylcytosine (5mC) and oxidized cytosines are then lost from the early embryo in a 'passive' or replication-dependent manner, resulting in the loss of nearly all modified cytosines by the 16-cell stage 103, 105 . Imprinted loci retain methylation 183 and some repetitive element classes 184 retain partial methylation. Approximately when the blastula implants into the uterus, the inner cell mass, which gives rise to the embryo, undergoes mass de novo DNA methylation 105, 183 . TET1 and TET2 are highly expressed at this stage, potentially fine-tuning methylation patterns. b | Demethylation also occurs in primordial germ cells (PGCs) between embryonic days E9.5 and E13.5 of embryonic development 80, 120, 128 . This event also entails both mass 5mC oxidation by TET1 and TET2 and loss of modified cytosine by passive demethylation, resulting in the loss of imprints. A similar process of 5mC oxidation and demethylation occurs more slowly in human germ cells 185 . This demethylation of imprints is critical because whereas somatic cells of an organism contain male and female imprints, the germ cells of an organism contain the imprints that correspond exclusively to the gender of the organism. Germ cells are then gradually re-methylated and imprints placed, starting at E15 in males and after birth in females 186 .
TET1 and TET2 in ES cells
Inbred mouse strain
Experiments are typically conducted using inbred mouse strains, in which all mice are genetically extremely similar. C57BL/6 is one of the most frequently used strains. 129P2/OlaHsd is another inbred mouse strain. The same mutation can have different effects in different backgrounds
Gene-trap
A mutant in which a gene is disrupted by the random insertion of transgenic DNA that contains a splice acceptor site followed by stop codons. TET2 in differentiation is minor. Overall, the data indicate that, despite the abundance of 5hmC in ES cells, TET1 and TET2 have modulatory but not essential roles in mouse development, ES cell survival or pluripotency. Whether TET3 can compensate for the loss of TET1 and TET2 has not yet been established.
Nevertheless, the catalytic activity of TET proteins may be important in ES cells and the inner cell mass from which they are derived, because of the underlying biology of these cells. ES cells approximately recapitulate the stage of development in which large-scale de novo methylation of the genome occurs (FIG. 3) . Because transcriptional initiation antagonizes methylation 71, 87 , genes with lower levels of transcription are presumably more susceptible to aberrant increases in DNA methylation. As methylation is generally maintained through cell divisions, aberrant methylation may be inconsequential at early embryonic stages but deleterious during later development. Thus, the function of TET proteins in the inner cell mass may be to repress lineage-specific genes, while simultaneously antagonizing methylation to permit activation of these genes later in development. Accordingly, in ES cells, both TET1 and 5hmC are enriched at promoters that contain dual H3K4me3 and H3K27me3 marks, which are so-called 'poised' promoters that can be activated later in development 74, 76 . Loci with high levels of 5fC in ES cells show increased cytosine methylation in TDG-deficient MEFs 83 , even though TET1 and TET2 are almost absent from MEFs. Thus, a demethylation defect in early development seems to result in excess methylation at a later stage.
Generally, the data support a real but limited role for TET1 and TET2 in demethylation in ES cells. Bisulphite sequencing of selected loci in TET1-deficient ES cells does indicate a very modest increase in methylation level s 39 . Mass spectrometry indicates that cells deficient in both TET1 and TET2 show an increase in 5mC levels (from 5.3% to 5.8% of all cytosines) and a smaller absolute drop in 5hmC levels (from 0.13% of all cytosine to undetectable) 124 . Thus, there is a ~1.05-fold increase in the total levels of cytosine modification (5.43% to 5.8%). If the increase in cytosine modification is concentrated at promoters at which CpG levels are high and TET proteins are most active, this could have a strong impact on transcription and development. However, caution must be used in extrapolating changes in methylation observed in ES cells, which undergo many generations of division in culture, to the inner cell mass that differentiate s quickly.
Most tissues in Tet1 −/− Tet2 −/− mice show modes t increases in total cytosine modification levels as measured by mass spectrometry, although it is unclear whether this is due to inadequate demethylation in the blastula, during later embryonic development or in adult tissue. The incompletely penetrant lethal phenotype of Tet1 −/− Tet2 −/− mice (BOX 3) could reflect a model in which, by stochastic variation, some mice acquire excess methylation at key promoters in early development, leading to subsequent lethality, whereas other mice do not. However, the perinatal lethality of Tet1 −/− Tet2 −/− mice cannot be assumed to be caused by alterations in DNA methylation. Furthermore, virtually all of the Tet1 −/− Tet2 −/− mice develop to birth with fully developed organs, so any dysregulation of methylation is necessarily fairly mild.
TET proteins in PGCs. PGCs undergo a rapid drop in 5mC levels between E9.5 and E10.5 (FIG. 3) . As in zygotes, this apparent demethylation event corresponds to mass conversion of 5mC to 5hmC, in this case mediated by TET1 and TET2 (REFS 80, 127) . There is no detectable formation of 5fC or 5caC as measured by immunocytochemistry 80 . Measurement of individual loci during germ cell development indicates that 5mC is replaced by 5hmC between E9.5 and E11.5, and that both marks are subsequently lost at a rate consistent with dilution by replication, as opposed to active removal 80 . Thus, if TET proteins are mediating demethylation in PGCs, it is by facilitated passive demethylation. However, even this mechanism may not be critical, as UHRF1 and DNMT3B levels are quite low in PGCs 128 and thus passive demethylation could occur without TET activity.
Germ cells derived from mouse Tet1 gene-trap mutants (BOX 3) have almost normal methylation leve ls 129 . At E13.5, when demethylation is complete, an increase in methylation corresponding to less than 1% of the total cytosines at CpG sites is observed in TET1-deficient cells 129 . A much greater effect is seen at the level of gene expression: loss of TET1 causes dys regulation of ~1000 genes, 90% of which are positively regulated by TET1, indicating that TET1 primarily
Box 3 | Phenotypes of TET-deficient mice
Ten-eleven translocation (Tet1) -/-mice on a mixed C57BL/6 × 129 inbred mouse strain background are born at Mendelian ratio and appear healthy despite a low birth weight 123 . Mouse Tet1 gene-trap mutant animals show embryonic lethality on a 129P2/OlaHsd mouse strain background, with noticeable abnormalities by embryonic day E8.5, but they are viable and fertile on a C57BL/6 background 129 . Female Tet1 gene-trap mutants have smaller litters, similarly to Tet1 -/-mice. In female Tet1 gene-trap mutants, which have smaller ovaries, about half of the developing female gametes display a defect in meiotic synapsis and suffer a developmental arrest between E16.5 and E18.5 (REF. 129 ). Whether Tet1 -/-mice have a similar meiotic defect is unknown.
Tet2
-/-mice on C57BL/6 or mixed backgrounds are born at Mendelian ratios and are fertile, but display clear haematological abnormalities. They have more haematopoietic stem cells (HSCs) than normal mice, and their HSCs have enhanced self-renewal and proliferative potential in culture and in experiments in which progenitor cells are serially transferred in mice [154] [155] [156] [157] . At 4 months old, one strain of Tet2 -/-mice has been reported to develop a condition similar to human chronic myelomonocytic leukaemia (CMML), a malignancy typified by a gross abundance of monocytes 155, 157 . A Tet2 gene-trap strain shows perinatal lethality 158 , but because this phenotype is not observed in several conventional Tet2 gene-disrupted strains, it is most likely an artefact.
Tet1 -/-Tet2 -/-mice on a mixed C57BL/6 × 129 background are born at near Mendelian ratios and have fully developed organs, but roughly half of these animals die perinatally, often with visible defects in head development 124 . Surviving mice have a smaller birth and adult weight, and females have reduced ovary size and fertility, producing litters of about one fourth the normal litter size. 113 .
Meiotic synapsis
The event in meiosis prophase I in which homologous chromosomes align to allow recombination of genetic material (known as 'crossing over'). −/− Tet2 −/− mice show aberrant methyl ation. The occurrence and degree of increased methyl ation varies across loci and between individual mice. This is consistent with mass genomic demethylation proceeding normally in TET-deficient animals, but the subsequent erasure of imprints being variably impaired to cause fatal defects in some, but not all, progeny.
Thus, in the two instances of mass demethylation in mammals, essentially the same pattern occurs. 5mC is oxidized en masse by TET3 in zygotes and TET1 and TET2 in PGCs, predominantly producing 5hmC, and there is little evidence that the oxidized methylcytosines are excised. Rather, all modified cytosines are diluted out during subsequent cell divisions, due to the expression of DNMT1O in zygotes and the downregulation of UHRF1 in PGCs. Insofar as oxidized methylcytosines are promoting demethylation in these systems, they probably achieve this by antagonizing maintenance methylation under conditions in which this process is already in efficient. Potentially, the oxidized methyl cytosines have important functions that are not related to their removal as, for example, epigenetic marks.
TET proteins in reprogramming
The transfection of developmentally-committed cells with certain combinations of transcription factors can reprogramme them, with low efficiency, into induced pluripotent stem (iPS) cells that are phenotypically similar to ES cells 130 . The classic combination of transcription factors used in these experiments is OCT4 (also known as POU5F1), SOX2, Krüppel-like factor 4 (KLF4) and MYC (collectively referred to as OSKM), although other combinations have also been used successfully 131 . For efficient reprogramming, endogenous pluri potency factors must be activated and their promoters and enhancers demethylated 132 . Although TET proteins are apparently dispensable for pluripotency in ES cells and in vivo, several recent publications indicate roles for TET1 and/or TET2 in the generation of iPS cells, although they do not report a common mechanism. Specifically, one study showed that the depletion of TET2 by shRNA completely ablated reprogramming of fibroblasts by OSKM, and that the Nanog promoter was hydroxymethylated and demethylated during the first 4 days after reprogramming 133 . These findings, together with the fact that TET1 and TET3 expression was not observed during this time frame, suggest that TET2 has a role in generating iPS cells. In another study, TET1 and TET2 were shown to physically interact with Nanog in ES cells, and co-transfection of Nanog with either TET1 or TET2 greatly enhanced OCT4, KLF4 and MYC-mediated reprogramming of neural stem cells 134 . The authors proposed that Nanog and TET1 or TET2 could co-activate the endogenous Oct4 and Esrrb (oestrogen-related receptor beta) genes via a mechanism that involves at least some demethylation. A third study showed that co-transfecting TET1 with OSKM factors greatly enhances the reprogramming of fibroblasts 135 . These data suggest that TET1 mediates the oxidation and demethylation of the Oct4 promoter and proximal enhancer, and that TET1 can substitute for OCT4 in OSKM-dependent reprogramming transfection. In all of the above cases, demethylation of the target loci is slow enough to be caused by a passive mechanism. The requirement for TET proteins in reprogramming clearly varies depending on the precise conditions and status of the starting cell lines. However, the ability of TET protein s to generate oxidized methylcytosines and antagonize methylation of select loci may help to establis h the pluripotent state.
TET proteins in the nervous system The brain consistently has the highest levels of 5hmC of any mammalian tissue. This may in part reflect the abundance of long-lived post-mitotic cells in the nervou s system, such that 5hmC can accumulate in neurons without being depleted through replication. It is still largely unknown how TET deficiency influences mouse brain development. Increased 5hmC and decreased DNA methylation clearly correlate with higher gene expression levels and a more open chromatin state in neural cells 85 but causality has not been established. Depletion of TET2 and TET3 in the developing mouse cortex, by in utero electroporation of shRNA, causes a block in the differentiation of neural progenitor cells into neurons 77 . Xenopus laevis embryos injected with morpholinos targeting tet3 develop a gross defect in early development, that features loss of expression of critical eye and neural markers and results in small heads and no eyes 42 . The phenotype was partly rescued by injection of mRNA coding for a catalytically inactive TET3, whereas injection with a TET3 CXXC domain mutant provided no rescue at all. Thus, TET3 has a role in normal head development in X. laevis. It is unknown whether the perinatal lethality observed in Tet3 −/− mice 113 is linked to a neurological development defect.
Interpreters of 5mC oxidation
As the extent to which 5mC oxidation products are demethylation intermediates is unclear, other mechanisms by which they could influence transcription should be considered. Some transcriptional regulators and chromatinassociate d proteins specifically recognize 5hmC or other oxidized methylcytosines. Mass spectrometry has been
Box 4 | Effects of hydroxymethylation on methylation-based silencing
Methyl CpG-binding protein 1 (MBD1), MBD2 and Kaiso specifically recognize methylated DNA and recruit histone deacetylases or repressive histone H3 Lys9 methyltransferases (H3K9MTs) to 5mC [159] [160] [161] [162] [163] [164] . 5-hydroxy methylcytosine (5hmC) strongly inhibits the binding of these MBD proteins to DNA 49, 108, 165 and therefore is thought to induce transcriptional activation (see the figure, part a) . However [169] [170] [171] , may bind 5hmC in addition to 5-methylcytosine (5mC) 49, 85 . Various other transcriptional modulators bind 5mC selectively, and whether and how 5mC oxidation perturbs their activity is unclear 136 . DNA methyltransferases (DNMTs), including DNMT1, recruit histone deacetylases (HDACs) and H3K9 methyltransferases to DNA. At promoters, this perpetuates a repressive chromatin state through cell division 172 (see the figure, part b). As 5hmC potentially prevents DNMT1 recruitment, hydroxymethylation could block this mechanism of methylation-mediated silencing in dividing cells (FIG. 1c) .
5mC can prevent chromatin remodellers that possess CXXC domains from binding to DNA (see the figure, part c) 34 . These include the H3K4 methyltransferase mixed-lineage leukaemia (MLL) 38 , CXXC1, a component of the SET1 H3K4 methyltransferase complex 173 , and Lys-specific demethylase 2A (KDM2A), which removes H3K36 methylation marks 37 . It is unlikely that these proteins could bind oxidized 5mCs.
Methylation increases nucleosome compaction (see the figure, part d), and this is likely to reduce the accessibility of adjacent DNA to transcription factors in vitro 174 . How hydroxymethylation affects nucleosome compaction is unknown, although 5hmC-rich Purkinje neurons have markedly decondensed nuclei.
In some instances, cytosine methylation physically blocks the binding of a transcription factor (TF) to its target sequence 175, 176 (see the figure, part e). Alternatively, by blocking binding of repressors or insulators, methylation can actually increase the expression of a locus [177] [178] [179] [180] . If the binding of a transcription factor is inhibited by methylation, it is unlikely that methylcytosine oxidation would restore binding. Furthermore, as 5hmC is bulkier than 5mC, it may block the binding of proteins that tolerate 5mC.
Finally, quantum mechanical calculations indicate an inherent role for 5mC in stabilizing DNA duplexes by promoting base stacking interactions 181 . Recent experiments confirm that methylated DNA has a higher melting temperature than unmodified DNA, suggesting that methylation may directly inhibit transcriptional initiation or elongation by RNA polymerase (RNA Pol) by preventing necessary melting of the template (see the figure, part f) 182 . By contrast, 5hmC reduces the melting temperature of DNA duplexes to promote transcriptional elongation.
used to identify proteins bound selectively to 5hmC-containing DNA oligonucleotides in ES cells, neural progenitor cells and mouse adult brain 136 . Proteins that were found to bind to 5hmC included the neural progenitor cell-specific protein UHRF2, which presumably recognizes 5hmC-containing DNA via its SAD/ SRA domain, transcription factors such as zinc-fingers and home oboxes protein 1 (ZHX1), ZHX2 and THAP domain-containing protein 11 (THAP11), as well as several uncharacterized proteins. An important limitation of this study is that it does not distinguish between proteins that bind directly and indirectly to 5hmC. Despite the inability of glycosylases to cleave 5hmC in vitro 52 , several glycosylases and DNA repair proteins were found to associate with 5hmC in this study, suggesting that 5hmC may be a target of DNA repair 136 . In addition, two methyl-binding proteins, methyl CpG binding-protein 2 (MeCP2) and methyl-CpG binding domain protein 4 (MBD4), were shown in this and other studies to bind to 5hmC 85, 136, 137 . However, an initial finding that MBD3 (REF. 96 ) preferentially binds to 5hmC over 5mC has not been reproducible 49, 136 . TDG specifically binds 5fC and 5caC in vitro 53 and might therefore be a reader of 5fC and 5caC. Indeed, 5fC and 5caC were found to bind TDG in mouse ES cell, as well as a substantial population of DNA repair proteins, several transcription factors and a number of miscellaneous proteins, some of which may simply bind formyl or carboxyl groups nonspecifically 136 . A suggestion that TDG recruits the histone acetyltransferase p300 (REF. 138 ) is countered by the finding that the number of p300-binding sites in the genome actually increases in TDG-deficient ES cells 55 . However, TDG could nevertheless be a transcriptional regulator, as it has been reported to interact with multiple DNA-binding transcripti on factors 139 . Oxidized methylcytosines can affect Pol II processivity directly. 5mC and 5hmC have a relatively small effect on polymerase processivity in vitro, but a single 5fC or 5caC can drastically stall the progression of Pol II on a recombinant substrate 140 . This phenomenon is functionally and perhaps also mechanistically analogous to that observed with base J, which has a crucial role in transcriptio n termin ation in kinetoplastids 25 . Finally, methylcytosine oxidation could antagonize 5mC-mediated silencing. Six different mechanisms for methylation-based silencing have been demonstrated
. The relative importance of each mechanism is unclear, but their relevance clearly varies across cell types and loci. The impact of methylcytosine oxidation on these silencing mechanisms is also likely to be variable. Thus, in order to understand how 5hmC influences transcription at a locus, it may first be necessary to determin e how methylation mediates silencing at that locus.
Conclusions and future directions
The discovery of TET proteins has provided a new perspective on how DNA modification influences gene expression. There are now several potential mechanisms by which TET proteins and oxidized methylcytosines might mediate DNA demethylation, but whether and how these mechanisms contribute to gene regulation in different cell types remains to be elucidated. It will be important to determine how proteins that bind oxidized methylcytosines contribute to gene regulation and how the enzymatic activities and biological roles of TET proteins are influenced by interactions with other protein complexes. The ongoing development of improved methods for mapping oxidized methylcytosines promises to advance the field substantially, especially if it can be applied at single-base resolution to small numbers of differentiating cells. A careful analysis of changes in the distribution of oxidized methylcytosines, transcription levels, transcription factor binding and chromatin modifications in cells from animals lacking one or multiple TET proteins will also be essential to further our understanding of how TET proteins modulate gene expression, cell differentiation and function. 
